(Reuters) -The U.S. Food and Drug Administration has approved British drugmaker GSK's blood cancer drug, Blenrep, in one ...

A combination of genetic tests for a "very complex" blood cancer could accurately predict if the disease is likely to return within 18 months of treatment, a study has found. This method picks up ...

Dr. Matthew Matasar discusses why stem cell transplant is still a standard, life-saving option in blood cancers and how CAR-T ...

Launched in 2024, the American Cancer Society Hematologic Cancer Collaborative unites a diverse network of national thought ...

A study carried out by a team of researchers from The Institute of Cancer Research, London, found that combining two types of ...

AUSTIN (KXAN) – September is National Blood Cancer Awareness Month, and for Kathy Miller, it’s also a time of reflection and gratitude. Three years ago, Miller noticed that walking from her home to ...

Blood tests that detect early cancer are coming to market. Could they lead to earlier diagnosis and treatment?

Malnutrition is a common but difficult-to-manage complication for people with cancer, especially those treated with intensive ...

September marked Blood Cancer Awareness Month—a crucial time to shine a light on blood cancers such as leukaemia, lymphoma, and myeloma. These diseases affect millions worldwide, impacting the body’s ...

A new blood test for cancer DNA — the genetic code that differentiates cancer from healthy tissue — allows doctors to ...

Deion Sanders said he thinks has more blood clots due to experiencing leg pain after recently being treated for bladder cancer.